Severe gastrointestinal mucositis following high dose melphalan therapy for multiple myeloma

被引：2
|
作者：
Sharma, Sanjeev Kumar [1 ]
Handoo, Anil [1 ]
Choudhary, Dharma [1 ]
Dhamija, Gaurav [1 ]
Gupta, Nitin [1 ]
机构：
[1] BLK Superspecial Hosp, Dept Hematooncol & Bone Marrow Transplant, New Delhi 110005, India
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2013年 / 19卷 / 05期
关键词：
Gastrointestinal mucositis; Chemotherapy; RISK-FACTORS;
D O I：
10.3748/wjg.v19.i5.784
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mucositis is a known complication following use of chemotherapy, but fatal mucositis is unusual and management of such cases may be challenging. Pathologically there is denudation of mucosa of gastrointestinal tract. Severe cases can develop ileus and even perforation of bowel wall. We report here a case of multiple myeloma who developed World Health Organization grade 4 gut mucositis following the use of high dose melphalan with the expulsion of "intestine-like" material. (C) 2013 Baishideng. All rights reserved.
引用
收藏
页码：784 / 785
页数：2
相关论文
共 50 条
  • [1] Severe gastrointestinal mucositis following high dose melphalan therapy for multiple myeloma
    Sanjeev Kumar Sharma
    Anil Handoo
    Dharma Choudhary
    Gaurav Dhamija
    Nitin Gupta
    World Journal of Gastroenterology, 2013, (05) : 784 - 785
  • [2] High dose therapy for multiple myeloma - Getting beyond high dose melphalan
    Giralt, S.
    Oazilbash, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 51 - 52
  • [3] Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy
    Nath, Christa E.
    Shaw, Peter J.
    Trotman, Judith
    Zeng, Lihua
    Duffull, Stephen B.
    Hegarty, Gareth
    McLachlan, Andrew J.
    Gurney, Howard
    Kerridge, Ian
    Kwan, Yiu Lam
    Presgrave, Peter
    Tiley, Campbell
    Joshua, Douglas
    Earl, John
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (05) : 484 - 497
  • [4] ERYTHROLEUKEMIA - FOLLOWING MELPHALAN THERAPY FOR MULTIPLE-MYELOMA
    FISHMAN, SA
    RITZ, ND
    NEW YORK STATE JOURNAL OF MEDICINE, 1975, 75 (13) : 2402 - 2404
  • [5] ASCT and high-dose melphalan in multiple myeloma
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2014, 15 (11): : E481 - E481
  • [6] Outpatient high dose melphalan in multiple myeloma patients
    Medoff, E
    Kassar, M
    Seropian, S
    Cooper, D
    BONE MARROW TRANSPLANTATION, 2005, 35 : S248 - S248
  • [7] High-dose melphalan in patients with multiple myeloma
    Moreau, P
    Le Bonniec, M
    Harousseau, JL
    BULLETIN DU CANCER, 1999, 86 (03) : 283 - 288
  • [8] HIGH-DOSE MELPHALAN FOR MULTIPLE-MYELOMA
    CAVO, M
    BACCARANI, M
    GOBBI, M
    TURA, S
    LANCET, 1983, 2 (8360): : 1194 - 1194
  • [9] Gastrointestinal Bleeding Secondary to High-Dose Melphalan Pretreatment in Patients with Multiple Myeloma Was Associated with the Mode of Melphalan Administration
    Ge, Qunfang
    Wang, Yi
    Zhu, Huiling
    Xu, Kaihong
    Sheng, Lixia
    Yan, Xiaoyan
    Ouyang, Guifang
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [10] Peripheral blood progenitor cell transplantation in multiple myeloma following high-dose melphalan-based therapy
    Goldschmidt, H
    Hegenbart, U
    Wallmeier, M
    Hohaus, S
    Engenhart, R
    Wannenmacher, M
    Haas, R
    ADVANCES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION AND MOLECULAR THERAPY, 1998, 144 : 27 - 35
12345